Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor

A.S. Beltran; X. Sun; P.M. Lizardi; Pilar Blancafort

doi:10.1158/1535-7163.MCT-07-0526

Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor

A.S. Beltran, X. Sun, P.M. Lizardi, Pilar Blancafort

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1080-1090
Journal	Molecular Cancer Therapeutics
Volume	7
Issue number	5
DOIs	https://doi.org/10.1158/1535-7163.MCT-07-0526
Publication status	Published - 2008

Access to Document

10.1158/1535-7163.MCT-07-0526

Cite this

@article{997a6d8fd5b443a0818fe3addc4d2d89,

title = "Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor",

author = "A.S. Beltran and X. Sun and P.M. Lizardi and Pilar Blancafort",

year = "2008",

doi = "10.1158/1535-7163.MCT-07-0526",

language = "English",

volume = "7",

pages = "1080--1090",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "5",

}

TY - JOUR

T1 - Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor

AU - Beltran, A.S.

AU - Sun, X.

AU - Lizardi, P.M.

AU - Blancafort, Pilar

PY - 2008

Y1 - 2008

U2 - 10.1158/1535-7163.MCT-07-0526

DO - 10.1158/1535-7163.MCT-07-0526

M3 - Article

SN - 1535-7163

VL - 7

SP - 1080

EP - 1090

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

IS - 5

ER -